Cardiovascular disease risk factors in polycystic ovary syndrome

scientific article published on January 2008

Cardiovascular disease risk factors in polycystic ovary syndrome is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1055/S-2007-992923
P698PubMed publication ID18181081

P2093author name stringAnuja Dokras
P433issue1
P921main subjectcardiovascular diseaseQ389735
polycystic ovary syndromeQ500816
polycystic ovaryQ5547896
P304page(s)39-44
P577publication date2008-01-01
P1433published inSeminars in Reproductive MedicineQ15724536
P1476titleCardiovascular disease risk factors in polycystic ovary syndrome
P478volume26

Reverse relations

cites work (P2860)
Q26822385Associations between TNF-α and interleukin gene polymorphisms with polycystic ovary syndrome risk: a systematic review and meta-analysis
Q51281730Atrial natriuretic peptide, copeptin and adrenomedullin levels in polycystic ovary syndrome: a case-control study.
Q51373655Cardiovascular disease risk characteristics of the main polycystic ovary syndrome phenotypes.
Q36795530Cardiovascular disease risk in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Q36896732Carotid Intima-Media Thickness Is Associated with Increased Androgens in Adolescents and Young Adults with Classical Congenital Adrenal Hyperplasia
Q36058191Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis.
Q37251943Clinical spectrum of premature pubarche: links to metabolic syndrome and ovarian hyperandrogenism
Q47212737Correlations Between Anthropometry and Lipid Profile in Women With PCOS.
Q61439146Dietary underreporting in women affected by polycystic ovary syndrome: A pilot study
Q90588144Effect of GLP-1 Receptor Agonists in the Cardiometabolic Complications in a Rat Model of Postmenopausal PCOS
Q39503792Effects of exercise and group counselling on body composition and VO2max in overweight women with polycystic ovary syndrome.
Q51236725Effects of vitamin D3 derivative--calcitriol on pharmacological reactivity of aortic rings in a rodent PCOS model.
Q37253000HMG-CoA reductase inhibitors: do they have potential in the treatment of polycystic ovary syndrome?
Q61515666Habitual dietary intake, eating pattern and physical activity of women with polycystic ovary syndrome
Q85090007Increased monocyte chemoattractant protein-1 levels indicating early vascular damage in lean young PCOS patients
Q87071021Localization of the Trace Elements Iron, Zinc and Selenium in Relation to Anatomical Structures in Bovine Ovaries by X-Ray Fluorescence Imaging
Q64921252Long-Lasting Androgen-Induced Cardiometabolic Effects in Polycystic Ovary Syndrome.
Q45392415Lower-limb veins are thicker and vascular reactivity is decreased in a rat PCOS model: concomitant vitamin D3 treatment partially prevents these changes.
Q35244129Mental health and physical activity in women with polycystic ovary syndrome: a brief review
Q37489471Metabolic and carbohydrate characteristics of different phenotypes of polycystic ovary syndrome.
Q82419051Obesity and polycystic ovary syndrome
Q51337942Pharmacological reactivity of resistance vessels in a rat PCOS model - vascular effects of parallel vitamin D₃ treatment.
Q37625653Plasminogen activator inhibitor-1 -675 4G/5G polymorphism and polycystic ovary syndrome risk: a meta analysis
Q83062366Polycystic ovary syndrome
Q51411759Polymorphisms of the insulin receptor and the insulin receptor substrates genes in polycystic ovary syndrome: a Mendelian randomization meta-analysis.
Q33789151Statins in the treatment of polycystic ovary syndrome
Q41856851Tailoring cardiovascular risk assessment and prevention for women: One size does not fit all.
Q50866777The relationship between copper, homocysteine and early vascular disease in lean women with polycystic ovary syndrome.
Q24234635Ultrasound-guided transvaginal ovarian needle drilling for clomiphene-resistant polycystic ovarian syndrome in subfertile women

Search more.